About Axol Bioscience
Axol Bioscience is a company based in Cambridge (United Kingdom) founded in 2013. Axol Bioscience has raised $13.28 million across 9 funding rounds from investors including Scottish Enterprise, Calculus Capital and European Union. The company has 29 employees. Axol Bioscience has completed 1 acquisition, including Phenocell. Axol Bioscience operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Cambridge, United Kingdom
- Employees 29
- SectorsHealthcare
- Email••••••••
- Website axolbio.com
- Social LinkedIn X Facebook
- Legal Name Axol Bioscience Ltd
- Date of Incorporation 21 Dec, 2012
- Jurisdiction CAMBRIDGE, ENGLAND
- Total Equity Funding$13.28M (USD)
in 9 rounds
- Latest Funding Round$2.8M (USD), Series A
Jan 2026
- InvestorsScottish Enterprise
& 10 more
- Employee Count29
- Investments & Acquisitions
Funding Insights of Axol Bioscience
Axol Bioscience has successfully raised a total of $13.28M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2.8 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.28M
- Total Rounds 9
- Last Round Series A — $2.8M
- First Round $1.3M
(Sep 2014)
- Investors Count 11
All 9 funding rounds of Axol Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $2.8M | Series A | – | Broadoak Capital Partners | |
| Apr 2022 | $4.2M | Series A | – | Calculus Capital, Par Equity | |
| Apr 2021 | $344,142 | Series A | – | – | |
| Oct 2020 | $366,923 | Grant | – | – | |
| Jun 2019 | $119,378 | Grant | – | – | |
| Aug 2017 | $3.23M | Series A | – | Calculus Capital | – |
| Sep 2016 | $805,299 | Grant | – | – | |
| Mar 2016 | $1.42M | Seed | – | – | – |
| Sep 2014 | $1.3M | Seed | – | Hermann Hauser, Darrin Disley | – |
11 investors in total: 8 institutional and 3 angel.
Investors in Axol Bioscience
Axol Bioscience has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Scottish Enterprise, Calculus Capital and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
UK venture capital investments are managed by Calculus Capital. | 1999 | calculuscapital.com | London, United Kingdom | |
Venture capital and natural capital investments are managed by Par Equity. | 2008 | parequity.com | Edinburgh, United Kingdom | |
Investments are directed by IIG toward life sciences startups. | 2020 | iigplc.com | London, United Kingdom | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom | |
Offers medical advisory services for the life science and biopharma industries. | 2014 | meltwind.co.uk | Cambridge, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | broadoak.com | - | |
JM Jonathan Milner | British angel investor, founder of Abcam, active in biotech and life sciences. | – | unknown_1c20b528a9f846ee8 | - |
HH Hermann Hauser | Serial entrepreneur, venture capitalist, co-founder of ARM Holdings, active angel investor | – | unknown_8cc79cfeb32e45b88 | - |
DD Darrin Disley | - | – | unknown_0f7ae32e5fd741c59 | - |
Investor details for Axol Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Axol Bioscience
16 people are tracked at Axol Bioscience (7 in leadership, 9 in team); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
Sonya A. | Head of HR | Leadership |
Duncan Borthwick | Head of Sales & Marketing | Leadership |
Oliver Richardson | Chief Financial Officer | Leadership |
Liam Taylor | Chief Executive Officer | Leadership |
Ashley Barnes | Chief Science Officer | Leadership |
Sapna Vyas | Head Of Service Delivery & Product Innovation | Leadership |
Sonya Ansell | Head, Human Resources | Leadership |
Mhairi Rodgers | Roslin Site Lead | Team |
Amaia Paredes-Redondo | Scientific Group Leader | Team |
Helena R. | Research Scientist | Team |
Sian Humphreys | Project Manager | Team |
Holly Rore, PhD | Senior scientist | Team |
Teodora Popovici | Marketing Communications Manager | Team |
Steven Broadbent | Electrophysiologist and Senior Scientific Support Manager | Team |
Jessica Tilman | Project Manager | Team |
JOHN GARDNER | Manufacturing Operations Manager | Team |
Complete people profiles for Axol Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axol Bioscience
Axol Bioscience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Phenocell.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cell-based assays and cellular models for drug discovery are provided. | phenocell.com | Paris, France | 2013 | Oct 2024 | •••• |
Complete acquisition details for Axol Bioscience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Axol Bioscience
4 dated milestones of Axol Bioscience across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Axol Bioscience is founded.
- Funding First funding round of $1.3M.
- Acquisition Acquires Phenocell.
- Funding Latest funding round, Series A, of $2.8M.
Competitors of Axol Bioscience
Axol Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Axol Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Axol Bioscience
The website of Axol Bioscience (axolbio.com) receives about 13.6K visits a month.
- Monthly visits13.6K
▲ 21.9% vs previous month
Websites whose visitors overlap most with Axol Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sutter.com | 100% | – | #1,404,750 | View details | |
ced.co.uk | ced.co.uk | 99% | – | #1,464,236 | – |
| axionbiosystems.com | 97% | 35.5K | #817,660 | View details | |
| labome.com | 96% | – | #1,076,354 | View details | |
scientifica.uk.com | scientifica.uk.com | 94% | – | #1,077,420 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Axol Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Axol Bioscience
Complete news archive for Axol Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Axol Bioscience
10 companies that operate in the same segment as Axol Bioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Axol Bioscience
Axol Bioscience was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Axol Bioscience is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Axol Bioscience is a funded company, having raised a total of $13.28M across 9 funding rounds to date. The company's 1st funding round was a Seed of $1.3M, raised on Sep 2014.
Axol Bioscience has 29 employees.
Axol Bioscience was founded in 2013 in Cambridge, United Kingdom, within the biotechnology sector. Human cells derived from healthy donors and patients with specific diseases are offered, alongside induced pluripotent stem cells and reprogramming services. Culture media, coating solutions, cytokines, growth factors, and related reagents are also provided to support cell-based research and applications. Operations focus on enabling advancements in disease modeling and drug discovery.
Axol Bioscience's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Axol Bioscience has made 1 acquisition, including Phenocell.
Axol Bioscience has 11 investors. Key investors include Scottish Enterprise, Calculus Capital, European Union, IIG PLC, and Par Equity.
Axol Bioscience operates through Axol Bioscience Ltd.